This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC London

Legal Notice

CLINICAL PHARMACY CONGRESS IS SPONSORED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. PHARMACEUTICAL COMPANIES HAVE SOLELY PROVIDED SPONSORSHIP THROUGH THE PURCHASE OF EXHIBITION SPACE AND/OR SPONSORED SPEAKER SESSIONS WITH NO FURTHER INPUT INTO THE ARRANGEMENTS OR AGENDA OF THE MEETING. SESSIONS DELIVERED WITH INPUT FROM OUR SPONSORS WILL ALWAYS BE MARKED ON THE PROGRAMME. A FULL LIST OF CONFIRMED SPONSORS FOR CLINICAL PHARMACY CONGRESS LONDON IS AVAILABLE HERE.  

CPC 2026 Content Programme

Subpage Hero

.

Loading

Strategic commissioning in the new NHS

08 May 2026
Clinical Theatre 1
Strategic commissioning in the new NHS

Integrated Care Boards are being reshaped as strategic commissioners and intelligent healthcare payers, with a clear expectation that they design, fund and assure high-value care rather than directly manage services. This session explores what that shift means in practice: using population insight, contractual levers and data to improve outcomes, reduce inequalities and live within financial allocation, while delegating delivery to providers. It will examine the leadership, capability and judgement required to hold grip on quality, safety and value in a more distributed and financially constrained NHS.

The NHS is entering a new phase in which Integrated Care Boards are expected to operate as strategic commissioners and intelligent healthcare payers, rather than direct service managers. This session explores what that shift really means in practice.

Drawing on the NHS England Strategic Commissioning Framework and emerging Model ICB thinking on medicines and system stewardship, it will examine how commissioners use their payor role to understand population need, plan and contract for high-value care, and monitor outcomes, inequalities and financial sustainability.

We will consider the increasing delegation of delivery to providers, the use of data and contractual levers to reduce unwarranted variation, and the risks of fragmentation or misaligned incentives if reform is poorly handled.

The session will focus on the leadership, capability and judgement required to commission boldly, transparently and responsibly in a financially constrained and politically sensitive environment

Speakers
Ewan Maule, Director of Medicines and Pharmacy - North East and North Cumbria NHS Integrated Care Board

Newsletter Sign Up